COVID-19 vaccination in the Central African Republic
| Date | May 20, 2021 |
|---|---|
| Cause | COVID-19 pandemic |
COVID-19 vaccination in the Central African Republic is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The Central African Republic began its vaccination program on 20 May 2021, initially using the 60,000 doses of the Covishield vaccine delivered through the COVAX facility.[1] As of 15 June 2021, 42,644 doses have been administered, 41,095 people with one dose and 1,549 people fully vaccinated.[2]
History
Timeline
May 2021
By the end of the month 19,290 vaccine doses had been administered.[3]
June 2021
By the end of the month 77,543 doses had been administered.[3]
July 2021
By the end of the month 94,600 doses had been administered.[3]
August 2021
By the end of the month 103,771 doses had been administered.[3]
September 2021
By the end of the month 187,160 doses had been administered.[3]
October 2021
By the end of the month 421,696 doses had been administered. 16% of the target population had been fully vaccinated.[3]
November 2021
By the end of the month 422,496 doses had been administered. 17% of the target population had been fully vaccinated.[3]
December 2021
By the end of the month 518,577 doses had been administered. 22% of the target population had been fully vaccinated.[3]
January 2022
By the end of the month 603,963 doses had been administered. 26% of the target population had been fully vaccinated.[3]
Progress
Cumulative vaccinations in the Central African Republic[4]
References
- ↑ "La République centrafricaine lance sa campagne nationale de vaccination contre la COVID-19" (in French). Unicef. 21 May 2021. Retrieved 26 May 2021.
- ↑ "owid/covid-19-data". GitHub. Retrieved 19 June 2021.
- 1 2 3 4 5 6 7 8 9 Africa COVID-19 dashboard (World Health Organization).
- ↑ "owid/covid-19-data". GitHub. Retrieved 7 March 2021.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
.svg.png.webp){kind=small}
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.